Global Coalition on Aging  

Member Profile: Novartis International AG

Novartis provides healthcare solutions that address the evolving needs of patients and societies through its innovative medicines, cost-saving generics, vaccines, diagnostics and consumer health products that include eye care and self-medication. In 2009, the group achieved net sales of $44.3 billion USD and invested $7.5 billion USD in R&D to tackle diseases with high unmet medical need.

Novartis supports healthy aging as a key policy objective in managing demographic change. We are committed to work in partnership and provide healthcare solutions to sustainably meet aging patients' needs.

Visit Member Website

Return to GCOA Members page